from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2322c/rocD1

LFCtreatmentdescriptionclass of inhibitor

0.033

Amikacinug/mL Amikacintranslation

-0.093

Cap5-10ug/mL Capreomycintranslation

-0.108

Rox10-50 ug/mL Roxithromycintranslation

0.095

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.291

Rif0.2-5ug/mL Rifampicintranscription

0.141

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.958

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.866

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.441

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.172

Clofazimine10-13 ug/mL Clofaziminerespiration

0.213

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.011

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.942

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

3.230

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.099

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.866

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.857

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.162

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.753

KCN5-20 ug/mL Potassium cyaniderespiration

-2.377

NaN30.2-2 mM Sodium aziderespiration

1.038

Nigericin50 uM Nigericinrespiration

1.006

TRC10-150 ug/mL Triclosanrespiration

1.172

TRZ10-25 ug/mL Thioridazinerespiration

1.246

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.179

menadione6-10 ug/mL Menadionerespiration

-0.598

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.706

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.726

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.331

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.166

NRP_1Non-replicating persistence stage 1dosRassociated

-0.804

Amp0.2mg/mL AmpicillincellWall

-0.352

Cephalexin20-100 ug/mL CephalexincellWall

-0.648

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.918

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.627

EMB10-20 ug/mL EthambutolcellWall

-0.600

Eta12-40 ug/mL EthionamidecellWall

-0.828

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.544

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.605

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.011

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.162

BZA0.12 mg/mL BenzamidearomaticAmides

0.148

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.389

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.114

H2O24 mM hydrogen peroxideDNAdamaging

-0.331

Levo10 ug/mL LevofloxacinDNAdamaging

-0.631

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.760

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.492

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.799

UVUV-irradiationDNAdamaging

-0.698

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.293

Antimycin12.5-50 ug/mL Antimycin A?

-0.369

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.167

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.261

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.397

PA8240.2-2 ug/mL PA-824?

0.489

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.155

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.120

Verapamil50 uM Verapamil?

0.286

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.486

methoxatin10-20 ug/mL Methoxatin?